Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Immune Therapeutics, Inc. (IMUN)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| | 10-Q | | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Assets |
| Cash and equivalents | 0.0 | | 0.2 | 0.4 | 0.5 | 0.0 | 0.0 | 0.0 |
| Other current assets | | | 0.0 | 0.4 | 2.6 | 2.7 | | |
| Total current assets | 0.0 | | 0.2 | 0.8 | 3.1 | 2.7 | 0.0 | 0.0 |
| Total assets | 0.8 | | 0.2 | 0.8 | 3.1 | 2.7 | 0.0 | 0.0 |
| |
| Accounts payable | 1.4 | | 1.4 | 2.2 | 2.2 | 2.2 | 2.6 | 2.7 |
| Accrued expenses | 0.1 | | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 |
| Short-term debt | 1.1 | | 0.7 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 |
| Short-term debt | 1.1 | | 0.7 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 |
| Other current liabilities | 1.3 | | 0.6 | 5.8 | 5.6 | 4.9 | 4.9 | 4.7 |
| Total current liabilities | 3.9 | | 2.8 | 11.3 | 11.1 | 10.4 | 10.9 | 10.8 |
| Total liabilities | 3.9 | | 2.8 | 11.3 | 11.1 | 10.4 | 10.9 | 10.8 |
| |
| Shareholders' equity [+] | -3.1 | | -2.6 | -10.5 | -7.9 | -7.7 | -10.9 | -10.7 |
| Paid-in capital | 380.8 | | 380.1 | 371.5 | 371.5 | 371.5 | 371.5 | 371.5 |
| Retained earnings | -383.9 | | -382.7 | -382.0 | -379.4 | -379.2 | -382.3 | -382.2 |
| Tangible shareholders' equity | -3.1 | | -2.6 | -10.5 | -7.9 | -7.7 | -10.9 | -10.7 |
|